Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.

Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Italy.
The Journal of Clinical Psychiatry (Impact Factor: 5.14). 02/1998; 59(2):60-8.
Source: PubMed

ABSTRACT The aim of this study was to explore patterns and clinical correlates of psychiatric comorbidity in patients with schizophrenia spectrum disorders and mood spectrum disorders with psychotic features.
Ninety-six consecutively hospitalized patients with current psychotic symptoms were recruited and included in this study. Index episode psychotic diagnosis and psychiatric comorbidity were assessed using the Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). Psychopathology was assessed by the SCID-P, Brief Psychiatric Rating Scale, Scale for the Assessment of Negative Symptoms, and Hopkins Symptom Checklist. Awareness of illness was assessed with the Scale to Assess Unawareness of Mental Disorders.
The total lifetime prevalence of psychiatric comorbidity in the entire cohort was 57.3% (58.1% in schizophrenia spectrum disorders and 56.9% in mood spectrum psychoses). Overall, panic disorder (24%), obsessive-compulsive disorder (24%), social phobia (17.7%), substance abuse (11.5%), alcohol abuse (10.4%), and simple phobia (7.3%) were the most frequent comorbidities. Within the group of mood spectrum disorders, negative symptoms were found to be more frequent among patients with psychiatric comorbidity than among those without comorbidity, while such a difference was not detected within the group of schizophrenia spectrum disorders. Social phobia, substance abuse disorder, and panic disorder comorbidity showed the greatest association with psychotic features. An association between earlier age at first hospitalization and comorbidity was found only in patients with unipolar psychotic depression. Patient self-reported psychopathology was more severe in schizophrenia spectrum patients with comorbidity than in those without, while such a difference was less pronounced in mood spectrum psychoses.
These findings suggest that psychiatric comorbidity is a relevant phenomenon in psychoses and is likely to negatively affect the phenomenology of psychotic illness. Further studies in larger psychotic populations are needed to gain more insight into the clinical and therapeutic implications of psychiatric comorbidity in psychoses.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The psychometrics of many self-report measures of anxiety and depression have been established for patients with anxiety disorders, but little is known about use of these measures in patients with psychotic disorders. This study examined psychometrics of commonly used self-report measures. Self-report measures and interviewer ratings were collected on 33 outpatients diagnosed with schizophrenia disorders. A sample of 46 patients with anxiety disorders completed the same self-report measures. Internal consistency was high for the self-report measures in both samples. Test-retest reliability was moderate to high. Scores on self-report measures were correlated with interviewer ratings and with scores on other self-report measures of similar constructs, supporting the convergent validity of the measures. Reliable and valid information about anxiety and depression can be obtained through administering the self-report measures to outpatients diagnosed with psychotic disorders. There was more overlap among measures than was expected, possibly because of poor discriminant validity. One explanation of this may be that anxiety constructs overlap more in patients with schizophrenia or related disorders than in non-psychotic populations.
    Journal of Psychopathology and Behavioral Assessment 01/2002; 24(4). DOI:10.1023/A:1020783101092 · 1.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aims of this study were to conduct a meta-analysis and meta-regression to estimate the prevalence rates for obsessive compulsive symptoms (OCS) and obsessive compulsive disorder (OCD) in schizophrenia, and to investigate what influences these prevalence rates. Studies were identified via an online OVID database search, including PsychInfo, Embase and Medline until December 2009. Forty-three studies summarizing outcomes for 3978 subjects met inclusion criteria. The mean OCD prevalence is 12.3%, slightly increasing to 13.6% after adjustment in meta-regression. The prevalence rate of OCS, defined as any obsession or compulsion is 30.7% (30.3% adjusted). Higher severity of OCS, DIGS assessment, and Sub-Saharan African origin of study are associated with a lower OCS/OCD prevalence rate, use of DSM-IV edition, Y-BOCS assessment and longer schizophrenia history are associated with a higher prevalence rate. The prevalence of OCS and OCD in schizophrenia is substantial, specifically in more chronic patient populations and is influenced by the method of assessment.
    Schizophrenia Research 12/2013; 152(2-3). DOI:10.1016/j.schres.2013.10.033 · 4.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Attachment theory offers an evolutionary explanation for the occurrence of panic states. The distance between a mother and child causes the sensation of fear. The experience of feared annihilation, an intense fear reaction (panic), is presented as a threat to the individual's cohesiveness, disrupting the mental representation of self-consciousness, specifically self-unity. Alterations in self-consciousness in schizophrenia are so important that they are mostly included among Kurt Schneider's first-ranked symptoms. Based on clinical trials, case reports, and brain imaging and pharmacological studies, a paradigm is proposed to explain the relationship between panic anxiety and psychosis. The psychosis-anxiety pathophysiology explanation needs further investigation into the brain areas that integrate self-monitoring with fear areas, but it seems possible to note the importance of the anterior cingulate cortex.
    Medical Hypotheses 08/2013; 81(5). DOI:10.1016/j.mehy.2013.08.021 · 1.15 Impact Factor